Clinical trial

Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers

NCT07688460

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Lecanemab Normalized identity: lecanemabView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-07-10

PhasePHASE4

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

LecanemabDRUG · verified · RxNorm: lecanemab

Sponsors & collaborators

The Fourth Affiliated Hospital of Zhejiang University School of Medicinelead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07688460 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.